Our Clinical Trials system is temporarily offline. Sorry for any inconvenience this may cause.
NCT ID | Study Title | Action |
---|---|---|
NCT02343692 | A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas | View |
NCT04389892 | Usefulness of Contrast Enhanced Harmonic Endoscopic Ultrasound for Pancreatic Cysts | View |
NCT00261092 | GEMOX: Oxaliplatin in Pancreatic Cancer | View |
NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | View |
NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | View |
NCT05268692 | Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP | View |
NCT05479292 | Allocating Resources for Cancer Care in Times of the Sars-CoV-2 Outbreak. Health Care Research | View |
NCT06131840 | A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors | View |
NCT05362344 | Colorectal Cancer Screening in Cystic Fibrosis | View |
NCT01497392 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | View |
NCT04131192 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | View |
NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | View |
NCT00279292 | Randomized Trial of EUS Neurolysis in Pancreas Cancer | View |
NCT04289792 | Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer | View |
NCT01954992 | Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer | View |
NCT01922492 | Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug. | View |
NCT05887492 | Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors | View |
NCT06694792 | Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst BIomarkers Detection (INCITE) Consortium | View |
NCT04956640 | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) | View |
NCT03823144 | Intravital Microscopy in Human Solid Tumors | View |
NCT06545344 | Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm | View |
NCT04025840 | Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | View |
NCT06758544 | A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination with Chemotherapy for Resectable Pancreatic Cancer | View |
NCT05529940 | NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | View |
NCT00547144 | Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer | View |
National Pancreatic Cancer Foundation provides access to clinical research studies. This information is provided by clinicaltrials.gov and is maintained by the National Library of Medicine (NLM). Neither NPCF nor the US government review or approve the safety and science of the studies on this website. Read the disclaimer for details.Â
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.
Copyright © 2024 – National Pancreatic Cancer Foundation | All Rights Reserved